UCLA Hematology/Oncology - Porter Ranch

Clinical research site in Porter Ranch, California

Part of UCLA

As of July 2026, 2 paid clinical trials are recruiting at UCLA Hematology/Oncology - Porter Ranch in Porter Ranch, California. Active studies at this site focus on Urothelial Carcinoma alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at UCLA Hematology/Oncology - Porter Ranch (2)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for Metastatic Castration Sensitive Prostate Cancer (mCSPC)

122 locations incl. Huntsville

Sponsor: Pfizer

Sex: Male·Age: 18+

Code: NCT07028853·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for Urothelial Carcinoma

144 locations incl. Gilbert

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT04879329·Phase 2·Recruiting·Listed May 2021

Apply to this trial

More research sites in Porter Ranch

UCLA Hematology Oncology - Porter Ranch (1 trial)
UCLA Porter Ranch Primary & Specialty Care (1 trial)

Explore more

Paid clinical trials in Porter Ranch, CA · California clinical trials